(Q54567702)
Statements
Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit. (English)
Lycke NY
Agren LC
Ekman L
Löwenadler B
1 April 1997
158
8
3936-3946